Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CoreCivic
CXW
$3.19B
| $3.76M | ﹤0.01% |
336,687
-29,391
| -8% | -$440K |
|
|
BPMC
2827
CALL
DELISTED
Blueprint Medicines
BPMC
| $3.74M | ﹤0.01% |
+64,000
| New | +$4.12M |
|
2828
Baytex Energy
BTE
$2.92B
| $3.74M | ﹤0.01% |
16,009,960
+12,059,958
| +305% | +$11.1M |
|
2829
iShares Select U.S. REIT ETF
ICF
$2.09B
| $3.74M | ﹤0.01% |
81,618
+20,860
| +34% | +$1.17M |
|
2830
Astec Industries
ASTE
$1.02B
| $3.73M | ﹤0.01% |
106,802
+36,013
| +51% | +$1.41M |
|
|
CHS
2831
DELISTED
Chicos FAS, Inc.
CHS
| $3.72M | ﹤0.01% |
2,886,488
+909,541
| +46% | +$3.13M |
|
|
EVRI
2832
DELISTED
Everi Holdings
EVRI
| $3.72M | ﹤0.01% |
1,127,127
+655,901
| +139% | +$6.69M |
|
2833
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $3.72M | ﹤0.01% |
34,500
-52,500
| -60% | -$6.04M |
|
2834
PUT
American Airlines Group
AAL
$10.6B
| $3.71M | ﹤0.01% |
304,500
+245,800
| +419% | +$5.6M |
|
2835
Interface
TILE
$2.22B
| $3.71M | ﹤0.01% |
490,668
+21,636
| +5% | +$302K |
|
2836
CALL
Snap
SNAP
$9.01B
| $3.71M | ﹤0.01% |
311,900
-54,600
| -15% | -$838K |
|
2837
Workiva
WK
$3.54B
| $3.69M | ﹤0.01% |
114,174
-104,563
| -48% | -$4.35M |
|
2838
PUT
Halliburton
HAL
$26.6B
| $3.69M | ﹤0.01% |
538,900
+29,700
| +6% | +$517K |
|
|
BDSI
2839
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.68M | ﹤0.01% |
971,620
+32,394
| +3% | +$159K |
|
2840
GCM Grosvenor
GCMG
$820M
| $3.68M | ﹤0.01% |
357,508
+342,068
| +2,215% | +$3.52M |
|
2841
PUT
Elevance Health
ELV
$85.5B
| $3.68M | ﹤0.01% |
+16,200
| New | +$4.41M |
|
2842
Cimpress
CMPR
$2.31B
| $3.67M | ﹤0.01% |
68,947
-14,900
| -18% | -$1.51M |
|
2843
Cato Corp
CATO
$66.1M
| $3.66M | ﹤0.01% |
342,852
+21,766
| +7% | +$329K |
|
2844
iShares US Basic Materials ETF
IYM
$1.25B
| $3.64M | ﹤0.01% |
52,606
-21,101
| -29% | -$1.82M |
|
2845
AZZ Inc
AZZ
$4.54B
| $3.64M | ﹤0.01% |
129,371
+54,935
| +74% | +$2.1M |
|
2846
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
| $3.64M | ﹤0.01% |
148,449
| – | – |
|
2847
Appian
APPN
$2.48B
| $3.63M | ﹤0.01% |
90,328
-28,379
| -24% | -$1.32M |
|
2848
Allogene Therapeutics
ALLO
$694M
| $3.63M | ﹤0.01% |
186,728
+11,594
| +7% | +$276K |
|
2849
CALL
Marathon Petroleum
MPC
$83.7B
| $3.63M | ﹤0.01% |
153,500
-109,600
| -42% | -$5.05M |
|
2850
Relmada Therapeutics
RLMD
$527M
| $3.62M | ﹤0.01% |
106,245
+100,832
| +1,863% | +$4.07M |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.